The Swiss drugmaker said that its fenebrutinib pill significantly reduced brain lesions in people suffering from relapsing forms of multiple sclerosis when compared to a group of patients on placebo, meeting the phase II trial's primary goal.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2zT9v4N
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Roche says new MS drug shown to reduce brain lesions
https://ift.tt/FIfBrSb
No comments:
Post a Comment